Rethinking Insulin Resistance In Aging: A Reserve-Oriented Clinical Framework
As we age, our bodies undergo many changes, and one significant shift can be in how our cells respond to insulin, a hormone crucial for managing blood sugar. This reduced response, known as insulin resistance, is often seen as a problem primarily related to diabetes. However, new insights suggest that in older adults, it’s much more complex, representing a broader decline in the body’s overall metabolic resilience.
This means that instead of just a single issue with how insulin signals, it’s a widespread problem affecting multiple organ systems. Several factors contribute to this age-related insulin resistance. For instance, our muscles can deteriorate (a condition called sarcopenia), and our fat tissue can change its structure and function (adipose tissue remodeling). Additionally, the tiny powerhouses within our cells, mitochondria, can become less efficient (mitochondrial dysfunction), and the body can experience persistent, low-level inflammation (often termed “inflammaging”). Even cells that have stopped dividing but remain active (cellular senescence) play a role.
The implications of this go beyond just blood sugar. This systemic insulin resistance can impact brain health, potentially contributing to issues like memory decline, depression, and overall physical frailty. Recognizing this broader picture is crucial for developing more effective strategies to maintain health as we age. This includes a combination of lifestyle adjustments, specific medications, and innovative therapies that target the fundamental biological processes of aging.
Source: link to paper